68Ga-PSMA PET/CT中模拟转移瘤的肝脏灌注相关假病灶
Hepatic Perfusion-Related Pseudolesion Mimicking Metastasis on 68 Ga-PSMA PET/CT.
PubMed 文献 · Clin Nucl Med · 2026-05-05
本文报道一例前列腺癌患者,68Ga-PSMA PET/CT显示肝VIII段楔形PSMA摄取增高。MRI未见局灶性病变,仅见轻度弥散高信号不伴ADC减低及一过性动脉期高强化,符合灌注相关假病灶而非转移瘤。
要点
- 68Ga-PSMA PET/CT肝内楔形摄取增高需警惕灌注假病灶
- MRI弥散高信号不伴ADC减低及一过性动脉期强化支持良性灌注改变
- 避免将肝脏灌注相关假病灶误判为前列腺癌肝转移
核心结论
- 肝脏楔形PSMA摄取增高可为灌注相关假病灶,而非转移瘤。
研究设计与样本
- 本文为单例病例报告,报道一例前列腺癌患者的影像学发现。
主要发现
- 68Ga-PSMA PET/CT显示肝VIII段楔形PSMA摄取增高。
- MRI未见局灶性病变,但见轻度弥散高信号不伴ADC减低及一过性动脉期高强化。
- 上述表现符合灌注相关假病灶而非转移性疾病。
临床怎么用
- 对PSMA PET/CT肝内楔形摄取增高病例,应结合MRI弥散及增强序列鉴别灌注假病灶。
局限性
- 本文为单例病例报告,结论的普遍适用性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PSMA is a critical cell-surface molecule and 68 Ga-PSMA PET has become an established imaging modality that improves disease localization for newly diagnosed and recurrent prostate cancer. We report a patient with wedge-shaped increased PSMA uptake in segment VIII of the liver. MRI demonstrated no focal lesion; however, mild diffusion hyperintensity without apparent diffusion coefficient reduction and transient arterial hyperenhancement were observed. These findings were consistent with a perfusion-related pseudolesion rather than metastatic disease.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Oksuzoglu K, Perktas L, Onner H, et al. Hepatic Perfusion-Related Pseudolesion Mimicking Metastasis on 68 Ga-PSMA PET/CT. Clin Nucl Med. 2026. PMID: 42148830. doi:10.1097/RLU.0000000000006520
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。